Blog + News Press release Clerkenwell Press Office 16/04/2024 Press release Clerkenwell Press Office 16/04/2024 Clerkenwell Health Launching Foundation Course For Psychedelic-Assisted Therapy Read More Press release Clerkenwell Press Office 20/03/2024 Press release Clerkenwell Press Office 20/03/2024 Veterans Charities Seek Volunteers With PTSD For Innovative New Psychoactive Drug Trial Read More Press release Clerkenwell Press Office 07/02/2024 Press release Clerkenwell Press Office 07/02/2024 Trial of New Psychedelic Drug Seeks Patients with Treatment-Resistant Depression Read More Press release Clerkenwell Press Office 11/11/2023 Press release Clerkenwell Press Office 11/11/2023 Patients Dosed with Xanamem in New London-Based Trial to Treat Brain Fog in Depression Read More Press release Clerkenwell Press Office 19/10/2023 Press release Clerkenwell Press Office 19/10/2023 First Patients Dosed With Methylone in London in Ground-Breaking Trial to Treat PTSD Read More Press release Clerkenwell Press Office 09/06/2023 Press release Clerkenwell Press Office 09/06/2023 Psychedelics clinical trial start-up Clerkenwell Health to sponsor PSYCH Symposium London 2023 Read More Press release Clerkenwell Press Office 27/10/2022 Press release Clerkenwell Press Office 27/10/2022 British clinical psychedelics start-up closes £2.1m seed funding round as first trial in London gets green light Read More Press release Clerkenwell Press Office 13/05/2022 Press release Clerkenwell Press Office 13/05/2022 Europe’s first commercial facility for psychedelic clinical trials to open in London Read More
Press release Clerkenwell Press Office 16/04/2024 Press release Clerkenwell Press Office 16/04/2024 Clerkenwell Health Launching Foundation Course For Psychedelic-Assisted Therapy Read More
Press release Clerkenwell Press Office 20/03/2024 Press release Clerkenwell Press Office 20/03/2024 Veterans Charities Seek Volunteers With PTSD For Innovative New Psychoactive Drug Trial Read More
Press release Clerkenwell Press Office 07/02/2024 Press release Clerkenwell Press Office 07/02/2024 Trial of New Psychedelic Drug Seeks Patients with Treatment-Resistant Depression Read More
Press release Clerkenwell Press Office 11/11/2023 Press release Clerkenwell Press Office 11/11/2023 Patients Dosed with Xanamem in New London-Based Trial to Treat Brain Fog in Depression Read More
Press release Clerkenwell Press Office 19/10/2023 Press release Clerkenwell Press Office 19/10/2023 First Patients Dosed With Methylone in London in Ground-Breaking Trial to Treat PTSD Read More
Press release Clerkenwell Press Office 09/06/2023 Press release Clerkenwell Press Office 09/06/2023 Psychedelics clinical trial start-up Clerkenwell Health to sponsor PSYCH Symposium London 2023 Read More
Press release Clerkenwell Press Office 27/10/2022 Press release Clerkenwell Press Office 27/10/2022 British clinical psychedelics start-up closes £2.1m seed funding round as first trial in London gets green light Read More
Press release Clerkenwell Press Office 13/05/2022 Press release Clerkenwell Press Office 13/05/2022 Europe’s first commercial facility for psychedelic clinical trials to open in London Read More
